Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk, Ozempic
Ozempic May Reduce the Risk of Alzheimer’s. That’s Huge for Novo Nordisk.
Ozempic and Wegovy, the two brand names under which the company sells the GLP-1 drug semaglutide, are already blockbusters.
Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats
Novo Nordisk wants the Food and Drug Administration (FDA) to prevent compounding pharmacies from manufacturing their own versions of the company’s popular weight loss drug Wegovy and diabetes treatment Ozempic,
Novo Nordisk asks US to stop compounding pharmacies from making weight-loss drug copies
Novo Nordisk on Tuesday asked the U.S. Food and Drug Administration to ban compounding pharmacies from making copycat versions of its popular weight-loss and diabetes drugs, which it said were too complex for those manufacturers to produce safely.
Novo seeks to block compounders' Ozempic copies
Novo Nordisk is pushing the FDA to block compounders from making copies of its Ozempic and Wegovy, saying the weight-loss treatments are too complex to safely replicate. Why it matters: It's the latest twist in the battle between pharma giants and compounders over the law that allows copies of patent-protected drugs amid shortages.
Ozempic maker Novo Nordisk wants the FDA to crack down on knockoff weight loss drugs
Ozempic maker Novo Nordisk (NVO) is asking the U.S. Food and Drug Administration (FDA) to prohibit compounding pharmacies from making off-brand versions of semaglutide, the active ingredient in its blockbuster weight loss and diabetes medications.
1h
on MSN
Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics
People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared ...
1h
on MSN
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
The insulin is facing supply shortages as diabetes patients increasingly turn to GLP-1 weight loss drugs such as Ozempic and ...
6h
on MSN
Novo’s Ozempic Linked to Reduced Alzheimer’s Diagnoses
Patients taking Novo Nordisk A/S’s Ozempic were at significantly reduced risk of being diagnosed with Alzheimer’s, according ...
4h
Active ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's disease: Study
The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may ...
The Economist
17h
It’s not just obesity. Drugs like Ozempic will change the world
Already one in eight American adults has been on glp-1 drugs. Novo Nordisk, maker of semaglutide, branded
Ozempic
for ...
1d
The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug
Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do ...
First for Women on MSN
1h
How To Boost the Weight-Loss Benefits of Ozempic With Easy Tips
Ozempic is arguably the buzziest buzzword in our culture today. But we still have plenty of questions about the type 2 ...
The Economist
7h
The economics of thinness (Ozempic edition)
Early man first invented tools. Then he invented jewellery. Archeologists have discovered strings of shells, believed to have ...
talker on MSN
26m
Drug in Ozempic may also help reduce risk of Alzheimer’s
A common diabetes and weight-loss drug may also reduce the risk of Alzheimer’s disease, according to a new study. American ...
studyfinds
16m
Ozempic for Alzheimer’s disease? Popular weight loss drug may also protect the brain
Could the drug that's changing the weight loss industry also protect older adults against the most common form of dementia? Scientists have exciting news about semaglutide.
The Economist
17h
GLP-1s like Ozempic are among the most important drug breakthroughs ever
More recently they have become a wildly popular way for people to lose weight. But in March semaglutide (a GLP-1 receptor ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Alzheimer's disease
Novo Nordisk
Wegovy
Christina Aguilera
Hannah Jiles
Feedback